IMO, it will go back to 15c after things are clear up tomorrow......then slowly back to 30c as they do more clinical trials in Australia for the next 4-5 month using FDA trials standard for both pediatric and adult to gather more data to improve their accuracy and announce these results (and more importantly regain market confidence).
From previous financials I don't think their capital expenditure were very high as they were doing the clinical trials so they have enough cash and it won't cost them much given they still have $8M cash on hand.
Then 4-5 month later, they will do both clinical trials for pediatric and adult, that is my call........
RAP Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
